Taxol (paclitaxel)

March 2, 2018March 2, 2018

Scientists Discover Gene Variant that Could Help Predict Chemo Outcomes

News

Researchers have discovered new gene variants that affect how ovarian cancer patients respond to standard chemotherapy treatments Paraplatin (carboplatin) and Taxol (paclitaxel). The variants influence how a patient processes chemotherapy medications. ... Read more

October 16, 2017October 16, 2017

First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery

News

The pharmaceutical development company NanOlogy has enrolled the first participant in its Phase 2 trial evaluating the safety and effectiveness of NanoPac, a new delivery method for the anti-cancer treatment ... Read more

September 27, 2017September 27, 2017

Chemotherapy Every 3 Weeks Seen as Effective as Weekly Dosing in European Ovarian Cancer Patients

News

Researchers compared weekly doses of Taxol (paclitaxel) to treat ovarian cancer with dosing every three weeks in a European trial to determine if weekly dosing was more effective. They found that ... Read more

April 10, 2017

TTFields, Taxol Combo Shows Promise in Recurrent Ovarian Cancer Patients

News

Patients with recurrent ovarian cancer may greatly benefit from the addition of Tumor Treating Fields (TTFields), a method that uses electric fields to disrupt cell division, to Taxol (paclitaxel), according to ... Read more

December 21, 2016

Phase 2 Trial Suggests TTFields-Chemotherapy Combo May Improve Outcomes in Recurrent Ovarian Cancer

News

Combining Tumor Treating Fields (TTFields), a method that uses electric fields to disrupt cell division, with Taxol (paclitaxel) may be a promising treatment approach for ovarian cancer patients, according to recent ... Read more